A Comparative Study of the Efficacy and Safety of Two Methods in the Treatment of Skin Wounds
A Single-Center Randomized Controlled Trial Comparing the Efficacy and Safety of Naked-Eye Observation Versus Microscopic Magnification Observation in the Treatment of Skin Wounds
1 other identifier
interventional
98
0 countries
N/A
Brief Summary
This study will compare the experimental group (debridement assisted by surgical microscope + VSD) and the control group (debridement under naked-eye observation + VSD) in terms of the rate of change in BWAT scores at one week postoperatively when the VSD is removed, daily wound negative-pressure drainage volume and pain scores within the first postoperative week, and results of two wound bacterial cultures. The study aims to scientifically evaluate the difference in efficacy between microscope-assisted debridement and naked-eye debridement, with the goal of providing a reference for the clinical debridement treatment of skin wounds.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2025
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 10, 2025
CompletedStudy Start
First participant enrolled
December 16, 2025
CompletedFirst Posted
Study publicly available on registry
January 7, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 31, 2027
January 7, 2026
December 1, 2025
1 year
December 10, 2025
December 23, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To compare the rate of change in wound scores between two methods of skin wound debridement.
the rate of change in wound scores= (BWAT score at 1-week post-debridement (VSD removal) - Pre-debridement BWAT score) / Pre-debridement BWAT score. The Bates-Jensen Wound Assessment Tool (BWAT) is a comprehensive, standardized instrument designed for the detailed assessment and documentation of wound characteristics. It is widely used by healthcare professionals, particularly in wound care, dermatology, and long-term care settings, to evaluate a variety of chronic wounds, including pressure injuries, venous stasis ulcers, diabetic foot ulcers, and surgical wounds. The strength of the BWAT lies in its structured approach. It assesses 13 key wound characteristics, each characteristic is scored from 1-5. The HIGHER the total score(13-65), the more severe the wound status.
one week
Secondary Outcomes (4)
To compare the daily volume of wound negative pressure drainage between the two groups within one week postoperatively
one week
To compare the daily pain scores of patients between the two groups within one week postoperatively
one week
To compare the rate of conversion from positive to negative in wound bacterial culture between the two groups at one week postoperatively
two weeks
To compare the length of hospital stay between the two groups
through study completion, an average of 1 month
Study Arms (2)
naked-eye
NO INTERVENTIONDebridement under naked-eye observation plus Vacuum Sealing Drainage (VSD)
microscopic
EXPERIMENTALDebridement under microscopic magnification assistance plus Vacuum Sealing Drainage (VSD).
Interventions
Eligibility Criteria
You may qualify if:
- Adult patients aged ≥18 years
- Patients with chronic skin wounds requiring surgical debridement due to causes such as trauma, diabetes, venous ulcers, or pressure injuries
- Patients whose systemic underlying medical conditions permit surgical tolerance
- Patients who agree to participate in the clinical study and provide signed informed consent
You may not qualify if:
- Presence of severe systemic immune diseases
- Known allergy to any component of the Vacuum Sealing Drainage (VSD) dressing
- Wounds with uncontrollable active major hemorrhage
- Visible bone fragments or internal fixation materials within the wound
- Pregnancy or lactation
- Inability to cooperate with or complete follow-up
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Deputy Director for Administration, Trauma Center
Study Record Dates
First Submitted
December 10, 2025
First Posted
January 7, 2026
Study Start
December 16, 2025
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
January 31, 2027
Last Updated
January 7, 2026
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
- Time Frame
- Sharing will begin within 6 months after the publication of the main study results in a peer-reviewed journal, last for 5 years.
- Access Criteria
- Data will be made available to qualified researchers whose study proposals have been approved by an independent Data Access Committee for the purpose of independent verification or secondary meta-analysis.
individual participant data, as well as the study protocol, statistical analysis plan, and clinical study report.